PDS Biotechnology Corporation

NasdaqCM:PDSB Stock Report

Market Cap: US$54.5m

PDS Biotechnology Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:PDSB Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
28 Feb 25BuyUS$25,001Stephen GloverIndividual15,061US$1.66
28 Feb 25BuyUS$25,000Gregory FreitagIndividual15,060US$1.66

Insider Trading Volume

Insider Buying: PDSB insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of PDSB?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,411,3913.11%
Institutions4,425,7229.75%
General Public39,558,73887.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 23.8%.


Top Shareholders

Top 25 shareholders own 12.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
3.32%
The Vanguard Group, Inc.
1,505,812US$1.8m-1.03%no data
1.52%
Frank Bedu-Addo
690,866US$829.0k0%no data
1.08%
BlackRock, Inc.
488,033US$585.6k-6.71%no data
0.98%
Richard Sykes
445,108US$534.1k0%no data
0.92%
Geode Capital Management, LLC
417,217US$500.7k0.51%no data
0.54%
Susquehanna International Group, LLP, Asset Management Arm
246,977US$296.4k84%no data
0.54%
IS Asset Management
243,570US$292.3k0%0.01%
0.49%
Citadel Advisors LLC
220,215US$264.3k91.5%no data
0.35%
William Blair Investment Management, LLC
157,500US$189.0k29.4%no data
0.29%
State Street Global Advisors, Inc.
133,333US$160.0k19.2%no data
0.28%
Millennium Management LLC
126,416US$151.7k-46%no data
0.27%
Gregory Conn
123,589US$148.3k0%no data
0.22%
Renaissance Technologies LLC
100,000US$120.0k331%no data
0.18%
Northern Trust Global Investments
82,532US$99.0k-11.1%no data
0.17%
Stephen Glover
78,851US$94.6k23.6%no data
0.17%
Commonwealth Equity Services, LLC
77,725US$93.3k-0.86%no data
0.17%
Inspirion Wealth Advisors, LLC
75,382US$90.5k2.52%0.01%
0.14%
Two Sigma Investments, LP
65,732US$78.9k273%no data
0.13%
Gregory Freitag
61,213US$73.5k32.6%no data
0.12%
Virtu Financial LLC, Asset Management Arm
54,693US$65.6k0%no data
0.11%
UBS Asset Management AG
50,058US$60.1k147%no data
0.086%
Marshall Wace LLP
39,024US$46.8k38.5%no data
0.079%
Jane Street Group, LLC, Asset Management Arm
35,644US$42.8k0%no data
0.065%
BNY Asset Management
29,293US$35.2k-0.01%no data
0.059%
Bank of America Corporation, Asset Management Arm
26,939US$32.3k0.01%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/11 03:04
End of Day Share Price 2025/05/09 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

PDS Biotechnology Corporation is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
Mayank MamtaniB. Riley Securities, Inc.
Kalpit PatelB. Riley Securities, Inc.